Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

Go back to Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
VERACYTE (NASDAQ: VCYT) Delayed: 53.63 --0 (-0%)
Previous Close $53.63    52 Week High $8.45 
Open $53.63    52 Week Low $4.21 
Day High $53.63    P/E N/A 
Day Low $53.63    EPS $-1.52 
Volume 794